eli lilly glp 1 lawsuit Novo Nordisk on Tuesday filed a against Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superior efficacy relative GLP-1 drug shortage sparks legal

J Endocrinol 219:R37R57 Rubinek T, Modan-Moses D (2016) Klotho and the growth hormone/insulin-like growth factor 1 axis: novel insights into complex interactions

In the literature on tendon repair, BPC-157 is described as promoting processes that include effects on cell survival and migration, suggesting that it may support cell behaviors necessary for organized tissue repair[1]

doi:10.1016/j.sxmr.2017.02.004 News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004, Kwon DR, Park GY

When lab work shows elevated CRP or other inflammatory indicators, and inflammation appears to be contributing to both obesity and depression, a GLP-1s anti-inflammatory effects become particularly valuable

doi: 10.1161/STROKEAHA.113.002637 83 ButovskyOZivYSchwartzALandaGTalpalarAEPluchinoSet al

Importantly, relatively few studies have directly linked these biomarkers to clinically meaningful outcomes such as live birth rates, which remain the most relevant endpoint in assisted reproduction